TY - JOUR
T1 - National survey of physicians in Japan regarding their use of diagnostic tests for legionellosis
AU - Kinjo, Takeshi
AU - Ito, Akihiro
AU - Ishii, Makoto
AU - Komiya, Kosaku
AU - Yamasue, Mari
AU - Yamaguchi, Tetsuo
AU - Imamura, Yoshifumi
AU - Iwanaga, Naoki
AU - Tateda, Kazuhiro
AU - Kawakami, Kazuyoshi
N1 - Funding Information:
Kazuhiro Tateda has received speaker honoraria from Pfizer Japan Inc. (Tokyo, Japan), MSD K.K. (Tokyo, Japan), Sumitomo Dainippon Pharma Co., Ltd. (Tokyo, Japan), Meiji Seika Pharma Co., Ltd. (Tokyo, Japan), and Taisho Toyama Pharmaceutical Co., Ltd. (Tokyo, Japan); research funding from Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan); grant support from Astellas Pharma Inc. (Tokyo, Japan), Daiichi Sankyo Co., Ltd. (Tokyo, Japan), Pfizer Japan Inc. (Tokyo, Japan), Taiho Pharmaceutical Co. , Ltd. (Tokyo, Japan), Taisho Toyama Pharmaceutical Co., Ltd. (Tokyo, Japan), Japan Blood Products Organization (Tokyo, Japan), Asahi Kasei Pharma Corporation (Tokyo, Japan), Sumitomo Dainippon Pharma Co., Ltd. (Tokyo, Japan), Shionogi and Co., Ltd. (Osaka, Japan), Meiji Seika Pharma Co., Ltd. (Tokyo, Japan), and Toyama Pharmaceutical Co., Ltd. (Tokyo, Japan); and donations from Kyorin Pharmaceutical Co., Ltd. (Tokyo, Japan), GlaxoSmithKline K.K.(Tokyo, Japan), Astellas Pharma Inc. , Meiji Seika Pharma Co., Ltd., Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., and MSD K.K.
Publisher Copyright:
© 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases
PY - 2022/2
Y1 - 2022/2
N2 - Introduction: Bacterial culture remains the gold standard for the diagnosis of legionellosis. However, past reports indicate that most physicians use the urinary antigen test (UAT) alone. Combining it with other tests is important, especially in patients with negative UAT results. The aim of this study was to investigate the current situation of legionellosis diagnostics and clarify the issues that need to be addressed. Methods: Between March 1, 2021 and April 30, 2021, a questionnaire survey was conducted in an anonymous manner among physicians working in Japan. Questionnaires were generated on a website and asked questions in a multiple-choice format. Results: Valid responses were received from 309 physicians during the study period. Most (92.9%) physicians reported using UAT as the initial test for patients suspected of having legionellosis, and <10% reported using other tests (e.g., culture, nucleic acid amplification test [NAAT], Gimenez staining, and serum antibody titer measurement [ATM]). When the initial test result was negative, 63% of physicians reported not conducting additional tests. Even when they chose to run additional tests, at most 27.8%, 23.6%, 12.3%, and 10.4% of all physicians used NAAT, culture, Gimenez staining, and serum ATM, respectively. The major reasons for not using tests other than UAT were “unavailability in the medical facility,” “long turn-around time,” and “difficult to collect sputum.” Conclusions: The present survey revealed that most physicians in Japan used UAT alone for diagnosing legionellosis. Eliminating barriers to creating a reasonable environment and edification of physicians are needed to improve the current situation.
AB - Introduction: Bacterial culture remains the gold standard for the diagnosis of legionellosis. However, past reports indicate that most physicians use the urinary antigen test (UAT) alone. Combining it with other tests is important, especially in patients with negative UAT results. The aim of this study was to investigate the current situation of legionellosis diagnostics and clarify the issues that need to be addressed. Methods: Between March 1, 2021 and April 30, 2021, a questionnaire survey was conducted in an anonymous manner among physicians working in Japan. Questionnaires were generated on a website and asked questions in a multiple-choice format. Results: Valid responses were received from 309 physicians during the study period. Most (92.9%) physicians reported using UAT as the initial test for patients suspected of having legionellosis, and <10% reported using other tests (e.g., culture, nucleic acid amplification test [NAAT], Gimenez staining, and serum antibody titer measurement [ATM]). When the initial test result was negative, 63% of physicians reported not conducting additional tests. Even when they chose to run additional tests, at most 27.8%, 23.6%, 12.3%, and 10.4% of all physicians used NAAT, culture, Gimenez staining, and serum ATM, respectively. The major reasons for not using tests other than UAT were “unavailability in the medical facility,” “long turn-around time,” and “difficult to collect sputum.” Conclusions: The present survey revealed that most physicians in Japan used UAT alone for diagnosing legionellosis. Eliminating barriers to creating a reasonable environment and edification of physicians are needed to improve the current situation.
KW - Legionella pneumophila
KW - Legionellosis
KW - Questionnaire
KW - Serogroup
KW - Survey
KW - Urinary antigen test
UR - http://www.scopus.com/inward/record.url?scp=85121374081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121374081&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2021.12.008
DO - 10.1016/j.jiac.2021.12.008
M3 - Article
C2 - 34933785
AN - SCOPUS:85121374081
SN - 1341-321X
VL - 28
SP - 129
EP - 134
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 2
ER -